Status:
COMPLETED
A Risk Based Approach to Improving Chronic Kidney Disease Management
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Harvard Vanguard Medical Associates
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
Aim 1: To assess whether quality of care for stage 3 chronic kidney disease can be substantially improved over 18 months by: * Point of care electronic alerts to primary care physicians recommending ...
Detailed Description
Specific Aim 1 We will develop software to calculate the estimated glomerular filtration rates for all patients presenting to primary care physicians randomized to the intervention arm, and identify p...
Eligibility Criteria
Inclusion
- Stage 3 chronic kidney disease based on at least 2 eGFR 30-60 (separated by 90 days) within the prior 5 years
- Must be at least 18 years of age
- Must have a primary care visit at one of 15 of the HVMA health centers within the last 18 months
Exclusion
- Age \> 85 years
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT01203813
Start Date
May 1 2011
End Date
January 1 2013
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harvard Vanguard Medical Associates
Newton, Massachusetts, United States, 02466